A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis
Clinical trial NCT05263817 · UNKNOWN
Trial details
- NCT number
- NCT05263817
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-08
- Primary completion
- 2024-10-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.